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CONGENITAL HEART DISEASE
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Objective: To review the evolution of the management approach for pulmonary atresia with intact
ventricular septum (PAIVS) in the past two decades and to assess its impact on patient outcomes.
Design and patients: Retrospective review of the management and outcomes of 94 patients (55 male
patients) with PAIVS diagnosed between July 1980 and August 2003.
Settings: Tertiary paediatric cardiac centre.
Results: Seven patients died before interventions. Of the remaining 87 patients who underwent
intervention at a median age of 9 days (from 1 day to 2 years), 12 had right ventricular outflow tract
reconstruction (RVOTR), 42 had closed pulmonary valvotomy (CPV), and 15 had laser assisted valvotomy
with balloon valvoplasty. A systemic–pulmonary shunt was inserted in 18 patients, six of whom had
subsequent RVOTR (n = 4) or laser assisted valvotomy (n = 2). Since 1990, catheter intervention
accounted for 38% (17 of 45) of the right ventricular outflow procedures. The mean (SEM) freedom from
reintervention was 93 (7)%, 71 (12)%, and 57 (13)% after RVOTR, 75 (7)%, 40 (8)%, and 14 (6)% after
CPV, and 54 (13)%, 24 (12)%, and 16 (10)% after laser assisted valvotomy at one month, six months, and
one year, respectively (RVOTR versus CPV, p , 0.001; RVOTR versus laser assisted valvotomy,
p = 0.001). Low cardiac output syndrome was significantly less common after catheter intervention than
after RVOTR (0% v 44%, p = 0.003) or CPV (0% v 29%, p = 0.01). The overall mean (SEM) survival was
77 (5)% and 70 (5)% at one and five years, respectively, and the overall mortality was 33% (29 of 87).
There were no significant differences in survival between the three groups.
Conclusions: Multiple interventions are often required in the treatment algorithm of PAIVS. The shift
towards increased use of the transcatheter approach has reduced the occurrence of postprocedural low
cardiac output syndrome.
I
n pulmonary atresia with intact ventricular septum
(PAIVS), morphological diversity of the right ventricle
(RV) and coronary arterial anatomy necessitates different
management strategies.1 2 Whereas univentricular repair and
heart transplantation are options for patients with a
diminutive RV or an RV dependent coronary circulation,2 3
one and a half and biventricular repairs are procedures of
choice for those with varying degrees of RV hypoplasia.2–4 In
the case of RV hypoplasia, early establishment of continuity
between the RV and pulmonary trunk is ideal, as it may
facilitate a definitive biventricular repair by promoting RV
growth.5–8
Surgical procedures including RV outflow tract reconstruc-
tion (RVOTR)4 9 and pulmonary valvotomy10 11 have been
used to relieve the outflow tract obstruction. In the past
decade, transcatheter laser12 or radiofrequency assisted13
pulmonary valvotomy has been added to the armamentarium
for the management of PAIVS. In selected patients with a
well developed tripartite RV, the radiofrequency assisted
valvotomy procedure has been shown to be more efficacious
in decompressing the RV and associated with lower
morbidity than closed surgical valvotomy and Blalock-
Taussig shunt insertion.14
Indeed, recent data from the UK and Ireland collaboration
study of pulmonary atresia with intact ventricular septum
suggest that increasing numbers of patients are undergoing
transcatheter pulmonary valvotomy as the initial procedure.15
Nonetheless, the impact of this evolution of management
strategy on patient outcomes remains unknown. As alluded
to by Daubeney and colleagues,16 the rarity of PAIVS limits
the population size to , 30 in more than 90% of the
published series. Given the paucity of clinical data, we
reviewed the evolution of management strategies over the
past 23 years in 94 infants and children with diagnosed
PAIVS and evaluated its impact on patient outcomes.
METHODS
Patients and data collection
We reviewed the clinical records of 94 patients (55 male
patients) with PAIVS diagnosed between July 1980 and
August 2003. The cardiac diagnosis was based primarily on
two dimensional and Doppler echocardiography, although
angiocardiography had been the mainstay of diagnosis in the
earlier years.
The following data were retrieved from the clinical records:
demographic data including age, weight, and year at
presentation; sex; the initial intervention offered, complica-
tions including low cardiac output syndrome and the
outcome; the need for and type of subsequent additional
interventions; for patients who died, the age at death and
cause of death; and for survivors, their further management,
follow up duration, and outcomes. Low cardiac output
syndrome was defined as the presence of clinical signs and
symptoms of the syndrome, as tachycardia, oliguria, cold
extremities, or cardiac arrest, with or without a > 30%
difference in arterial–mixed venous oxygen saturation or
metabolic acidosis.17
To determine the morphology of the RV, type of atresia
(muscular versus membranous), degree of tricuspid regur-
gitation, and coronary artery abnormalities, we reviewed all
Abbreviations: CPV, right ventricular outflow tract reconstruction;
PAIVS, pulmonary atresia with intact ventricular septum; RV, right
ventricular; RVOTR, right ventricular outflow tract reconstruction
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the echocardiographic and angiographic recordings at pre-
sentation. Morphological description of the RV was based on
the tripartite classification described by Bull and colleagues1
and degree of RV hypoplasia was assessed subjectively.
Additionally, the tricuspid valve annulus dimension was
measured at end diastole in the echocardiographic apical four
chamber view and expressed as a z score from normograms
based on postmortem data18 and contemporary echocardio-
graphic data.19 The degree of tricuspid regurgitation was
estimated as absent, mild, moderate, or severe either
angiographically or echocardiographically. Furthermore, the
presence of Ebstein’s malformation of the tricuspid valve was
noted. The coronary artery anatomy was studied from the RV
and aortic root angiograms and the presence of RV to
coronary artery fistulae was noted. An RV dependent
coronary circulation was defined by the presence of coronary
arterial interruption, stenosis of one or more of the major
epicardial arteries, or absent aortocoronary connection.
Surgical and transcatheter interventions
Ductal patency was maintained by prostaglandin E2 before
the surgical or transcatheter procedure. The management
strategy for PAIVS has evolved over the past two decades in
our institution. Between July 1980 and October 1991, 12
patients underwent RVOTR as the initial procedure. Between
December 1984 and December 1996, transventricular closed
pulmonary valvotomy (CPV), performed in 42 patients, had
become the mainstay of initial management as reported by
our group previously.20 Since its introduction in January
1996, transcatheter laser assisted valvotomy with balloon
pulmonary valvoplasty had been the initial procedure in 15
patients who did not have infundibular atresia and RV
dependent coronary circulation.12 In patients with severe RV
hypoplasia or RV dependent coronary circulation and in those
born preterm or having a low birth weight, the initial
palliative management was a systemic-pulmonary arterial
shunt.
After successful surgical or transcatheter establishment
of ventriculopulmonary continuity, prostaglandin infusion
was discontinued. If severe systemic oxygen desaturation
(, 70%) occurred, prostaglandin infusion was restarted.
Systemic–pulmonary arterial shunt was inserted in patients
who remained prostaglandin dependent for three weeks or
more and earlier in those who developed severe hypoxaemia
despite prostaglandin infusion. On the other hand, if the
patient showed evidence of progressive heart failure, ductal
ligation was performed.
Follow up
All of the survivors had serial echocardiographic assessment
to monitor RV growth, severity of residual RV outflow
obstruction, and degree of tricuspid and pulmonary regur-
gitation. The severity of pulmonary regurgitation was graded
as the ratio of the colour jet diameter to pulmonary annulus
in the parasternal short axis at the level of the RV outflow
tract.21 For patients with significant RV outflow obstruction
(a systolic pressure gradient . 50 mm Hg), balloon valvo-
plasty or RVOTR was performed as required. For those with
persistent systemic oxygen desaturation (, 90%) despite the
absence of significant RV outflow obstruction, device closure
of the atrial communication would be performed if a trial of
balloon occlusion was tolerated.22 A biventricular circulation
No further
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4
RVOTR
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2nd RVOTR
1
(death)
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angioplasty of
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occlusion
1
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3
Figure 1 Flowchart showing interventions and outcomes in patients undergoing primary right ventricular outflow tract reconstruction (RVOTR). ASD,
atrial septal defect; LPA, left pulmonary artery; PBPV, percutaneous balloon pulmonary valvoplasty; PDA, patent ductal artery; SP, systemic–pulmonary.
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Figure 2 Flowchart showing interventions and outcomes in patients undergoing primary closed pulmonary valvotomy (CPV).
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was considered to have been achieved if there was no
systemic oxygen desaturation together with the absence of
right to left interatrial shunt as documented by colour flow
mapping echocardiographically.
Statistical analysis
Results are expressed as mean (SD) or median (range) unless
otherwise stated. Differences in demographic data, RV
morphological variables, and types of initial inventions
between survivors and non-survivors were compared by
unpaired Student’s t test, Mann-Whitney U test, and Fisher’s
exact test where appropriate. Survival of patients and
freedom from the need for multiple interventions were
analysed by Kaplan-Meier actuarial survival analysis and
groups were compared by log rank test. A probability value of
p , 0.05 was considered significant. All statistical analyses
were performed with SPSS version 10.0 (SPSS, Inc, Chicago,
Illinois, USA).
RESULTS
Patients
All but two of the 94 patients were ethnic Chinese. The
median age at presentation was 1.5 days (range 1 day to
2 years) and the median weight was 3.2 kg (range 1.4 to 7.2).
Three patients had associated syndrome abnormalities,
namely Down’s syndrome, Noonan’s syndrome, and
Turner’s syndrome. Balloon atrioseptostomy was performed
in 15 patients. The atresia was membranous in 88 (93.6%)
and muscular in six (6.4%) patients. Four (4.3%) patients
had Ebstein’s malformation of the tricuspid valve. Although
20 (21.3%) had RV to coronary artery fistulae, only one
(1.1%) patient had RV dependent coronary circulation
diagnosed.
Surgical and transcatheter management
Seven patients died before any possible interventions. Of the
remaining 87 patients who underwent interventions at a
median age of 9 days (range 1 day to 2 years), 12 (14%) had
RVOTR, 42 (48%) had CPV, 15 (17%) had laser assisted
pulmonary valvotomy with balloon valvoplasty, and 18 (21%)
had insertion of a modified Blalock-Taussig shunt as the
initial intervention. Of the 18 patients with shunt insertion,
six eventually had their RV outflow opened by either RVOTR
(n = 4) or laser assisted valvotomy (n = 2). Figures 1 to 4
summarise the various interventions performed and the
outcomes.
Before 1990, the RV outflow was rendered patent by
surgery, RVOTR in 10 and CPV in 20 patients. On the other
hand, of the 45 patients undergoing RV outflow procedures
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3
Figure 3 Flowchart showing interventions and outcomes in patients undergoing primary laser assisted valvotomy and balloon valvoplasty.
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Figure 4 Flowchart showing interventions and outcomes in patients undergoing primary systemic–pulmonary (SP) shunt.
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after 1990, 17 (38%) had transcatheter interventions, 22 had
CPV, and six had RVOTR (p , 0.001).
Regardless of the initial intervention for establishment of
RV–pulmonary continuity, the need for one or more addi-
tional interventions was common. Overall, 52 of the 75 (69%)
patients who had their RV outflow opened required
additional interventions. The second interventions were
balloon pulmonary valvoplasty in 22 patients, systemic–
pulmonary shunt insertion with (n = 6) or without ligation
(n = 8) of arterial duct in 14, RVOTR in nine, isolated
ligation of arterial duct in five, device occlusion of atrial
septal defect in one, and balloon angioplasty for left
pulmonary artery stenosis in one. Twenty four patients
required three interventions and eight patients required more
than three interventions.
The mean (SEM) freedom from reintervention was 93
(7)%, 71 (12)%, and 57 (13)% after RVOTR, 75 (7)%, 40 (8)%,
and 14 (6)% after CPV, and 54 (13)%, 24 (12)%, and 16 (10)%
after laser assisted valvotomy at one month, six months, and
one year, respectively (fig 5). The need for reintervention was
significantly less after RVOTR than after both CPV
(p , 0.001) and laser assisted valvotomy (p = 0.001).
However, no significant difference was found between the
surgical and laser assisted valvotomy treated patients
(p = 0.88).
Complications and mortality
Low cardiac output syndrome was the main complication
after RVOTR, occurring in 44% (seven of 16) of patients. Of
the 42 patients who had CPV, 12 (29%) developed low cardiac
output syndrome, four (10%) required peritoneal dialysis for
oliguric renal failure, two (5%) had sepsis, and one (2%) had
the complication of subcapsular haematoma of the liver.
Among the 17 patients undergoing catheter interventions,
sepsis occurred in one (6%) and perforation of RV outflow in
another (6%). Low cardiac output syndrome was hence
significantly less common after catheter intervention than
after RVOTR (p = 0.003) or CPV (p = 0.01).
The overall mortality was 33% (29 of 87). Table 1
summarises the causes of early and late deaths. Early
postprocedural mortality (death within one month of
intervention) was 31% (five of 16) after RVOTR, 19% (eight
of 42) after CPV, and 12% (two of 17) after laser assisted
valvotomy. The early mortality after palliative shunt opera-
tion was 6% (one of 18). Univariate analyses found no
significant differences in demographic data, RV morphologi-
cal variables, type, and the year of the first intervention
between survivors and non-survivors (table 2).
Survival and outcomes
The overall mean (SEM) survival of the 87 patients under-
going interventions was 85 (4)%, 77 (5)%, and 70 (5)% at one
month, one year, and five years, respectively. With regard to
individual procedures, the survival was 81 (10)%, 62 (12)%,
and 56 (12)% after RVOTR, 81 (6)%, 76 (7)%, and 71 (7)%
after CPV, and 88 (8)%, 82 (9)%, and 82 (9)% after laser
assisted valvotomy at one month, one year, and five years,
respectively (fig 6). Although survival after primary CPV and
laser assisted valvotomy appeared to be better than that after
RVOTR, the difference was not significant (p = 0.43 and
p = 0.22, respectively).
The 58 survivors were followed up for 11.4 (5.6) years
(range 5 months to 23 years). One patient who had CPV and
a systemic–pulmonary shunt was lost to follow up after
immigration. Of the remaining 57 survivors, 39 (68%)
patients achieved a biventricular circulation, seven (12%)
had a univentricular repair, and two (3.5%) had a one and a
half ventricular repair. Six patients were considered likely
candidates for biventricular repair, pending either device
occlusion of atrial septal defect or RVOTR. One was
considered to be a candidate for one and a half ventricular
repair. The remaining two patients were managed conserva-
tively after the initial palliative systemic–pulmonary shunt
operation; one of them had hypoplastic pulmonary vascu-
lature and the other had pulmonary hypertension and severe
RV hypoplasia.
At the latest follow up, 43 (75%) patients were pink in
room air. Of the 39 patients who had completed the
biventricular repair, the degree of pulmonary regurgitation
was found to be mild in 24, moderate in 13, and severe in two
patients echocardiographically. Procedures pending were
device occlusion of atrial septal defect in five, RVOTR in
one, and left pulmonary artery stenting in one patient.
DISCUSSION
The present clinical series from a single institution illustrates
the evolution of management strategies over the past two
decades for the challenging condition of PAIVS. In patients
with a diminutive RV and RV dependent coronary circulation,
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Figure 5 Freedom from >1 interventions after primary surgical or
catheter opening of the right ventricular outflow tract.
Table 1 Causes of death after surgical and transcatheter
interventions
Cause of death
Number of
patients
RVOTR (n = 8)
Low cardiac output syndrome 7
Sudden death of unknown cause 1
CPV (n = 10)
Low cardiac output syndrome 7
Subcapsular haematoma of liver 1
Sudden death of unknown cause 2
Laser assisted valvotomy (n = 3)
Perforation of RVOT 1
Sepsis 1
Sudden death of unknown cause 1
SP shunt (n = 6)
Uncontrolled gastrointestinal bleeding 1
Necrotising enterocolitis 1
Sudden death of unknown cause 4
PBPV (n = 1)
Catheter induced arrhythmia 1
Post-Fontan procedure (n = 1)
Low cardiac output syndrome 1
CPV, closed pulmonary valvotomy; PBPV, percutaneous balloon
pulmonary valvoplasty; RVOTR, right ventricular outflow tract
reconstruction; SP, systemic-pulmonary.
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the management is palliative systemic–pulmonary arterial
shunt insertion and subsequent univentricular repair. In those
with anatomically suitable RVs, laser assisted valvotomy with
balloon valvoplasty has become the procedure of choice in our
institution. However, regardless of the initial procedure,
multiple interventions are often required in the subsequent
treatment algorithm, especially for patients after CPV and laser
assisted pulmonary valvotomy with balloon dilatation.
Nonetheless, the risk of developing low cardiac output
syndrome is significantly less after catheter intervention than
after either RVOTR or CPV. Although survival of patients after
RVOTR appeared worse than survival after CPV or primary
catheter intervention, the difference was not significant.
Survival of patients with PAIVS has been relatively poor
until recently. In the multi-institutional study reported by
Hanley and colleagues18 that constitutes the largest cohort of
surgical patients to date, the overall survival was 64% at four
years. The 56% and 71% five year survival of our patients after
RVOTR and CPV, respectively, concur with their findings18
and those reported previously.11 23 While transannular patch
opening of the RV outflow reduces the chance of residual
outflow obstruction, the possibility of acute RV failure,
especially in the presence of significant RV hypoplasia
(tricuspid valve z value , 4), remains an issue of concern.18 23
However, using a selective approach based on the RV growth
and coronary artery anatomy, Jahangiri and colleagues9
had an excellent surgical result of a zero mortality in 25
patients after RVOTR with or without concomitant systemic–
pulmonary arterial shunt insertion.
Notwithstanding the significantly improved survival after
RVOTR, CPV has its advocates.10 20 22 Surgical pulmonary
valvotomy is a relatively simple procedure that can be
performed by the transventricular20 or transarterial10 route
without the need for cardiopulmonary bypass, and it may
produce less RV damage and pulmonary regurgitation.22
Furthermore, in the presence of RV to coronary communica-
tions, it has been suggested that stepwise reduction of RV
pressure by initial survival valvotomy and later balloon
valvoplasty may potentially avoid compromising myocardial
perfusion secondary to RV steal, as the RV pressure usually
remains high after the initial valvotomy.10 However, as our
data show (fig 2), additional procedures are often required
after CPV. In the early postoperative period, 19% (8/42) of
patients required a systemic–pulmonary artery shunt after
CPV but in the intermediate and long terms, 64% (27/42)
required further relief of residual outflow obstruction by
either balloon valvoplasty or RVOTR.
The optimal surgical approach to relieve RV outflow
obstruction hence remains controversial. Additionally, the
need for concomitant systemic–pulmonary arterial shunt
insertion as part of the initial surgery is controversial.
Table 2 Comparisons of demographic, morphological, and surgical data between
survivors and non-survivors
Survivors (n = 58) Non-survivors (n = 29) p Value
Age at 1st procedure (days) 8 (1 to 307) 9 (1 to 757) 0.17
Weight at 1st procedure (kg) 3.2 (2.0 to 5.5) 3.2 (2.0 to 7.2) 0.66
Sex (male/female) 33/25 17/12 1.00
RV hypoplasia
Mild 19 9 0.37
Moderate 15 5
Severe 24 15
RV morphology
Monopartite 2 2 0.61
Bipartite 9 6
Tripartite 47 21
RV-coronary connection (yes/no) 11/47 9/20 0.28
Tricuspid regurgitation
Nil or mild 17 8 0.51
Moderate 10 6
Severe 31 15
Ebstein’s abnormality (yes/no) 2/56 2/27 0.60
Tricuspid valve dimension
Annulus size (mm) 10.4 (2.9) 9.8 (3.4) 0.49
Annulus z score* 21.2 (1.5) 21.5 (2.4) 0.52
Annulus z score 23.8 (2.5) 23.9 (2.7) 0.85
Type of primary procedure
RVOTR 7 5
CPV 30 12 0.24
Laser assisted valvotomy 12 3
SP shunt 9 9
Year of intervention (before/after 1990) 26/32 9/20 0.25
Data are median (range), mean (SD) or numbers.
*Calculated based on postmortem18 data; based on echocardiographic data.19
RV, right ventricular.
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Figure 6 Kaplan-Meier survival estimates for patients after primary
surgical and transcatheter interventions for establishment of right
ventricular–pulmonary trunk continuity.
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Concerns have been raised with regard to volume loading of
the left ventricle and reduction of systemic diastolic pressure
after shunt insertion.3 On the other hand, Hanley and
colleagues18 reported that concomitant shunt insertion during
RVOTR improves survival, possibly by preventing significant
hypoxia during the early postoperative period.
Data in the literature that compare the outcomes of
patients after surgical decompression of the RV with out-
comes after transcatheter valvotomy are limited.14 In a recent
study comparing the results of radiofrequency assisted
valvotomy and balloon dilatation with CPV and Blalock-
Taussig shunt, Alwi and colleagues14 concluded that trans-
catheter intervention is more effective in decompressing the
RV and is associated with a lower morbidity. It is important
to note, however, that patients selected for radiofrequency
assisted valvotomy have relatively well developed tripartite
RVs. The present study, however, failed to confirm a lower
reintervention rate after transcatheter opening of the RV
outflow. This may be related to our inclusion of patients
having moderately hypoplastic RVs (tricuspid valve z score as
small as –3.42) for catheter intervention as reported
previously.12
The atretic pulmonary valve was successfully perforated by
laser assistance in 94% (16 of 17) of our patients, which is
comparable with the 75–100% reported by various investiga-
tors.6 24–27 By avoiding primary RV outflow surgery, catheter
intervention may reduce the severity of RV damage and
morbidity caused by postoperative complications. Nonethe-
less, perforation of the infundibulum and sepsis are not
uncommon complications.6 24–26 At intermediate term follow
up, we12 and others6 have shown that, although the absolute
RV and tricuspid annulus dimensions increase after
catheter intervention, RV area25 and tricuspid annulus6 25
z values decrease progressively with somatic growth, suggest-
ing that a normal RV size may not be mandatory for
sustaining a biventricular circulation. However, it remains
unknown whether the RV growth is similar to that after
RVOTR or CPV. Nonetheless, the proportion of patients who
have achieved or are likely to achieve a biventricular
circulation is similar between patients undergoing primary
catheter intervention (11 of 14, 79%) and those undergoing
primary RVOTR or CPV (34 of 43, 79%, p = 1.0). Our data
compare favourably with the 64% (16 of 25) after catheter
intervention as reported by Humpl and colleagues25 and the
76% (19 of 25) after surgery.22
A number of limitations deserve comments. Firstly, the
relatively small number of patients undergoing primary
catheter intervention might have biased the outcome
analysis. Even so, our findings concur with those of a recent
study of 30 patients undergoing radiofrequency assisted
valvotomy.25 Secondly, the management strategies have
evolved over a period of two decades. Undoubtedly, the
surgical mortality has been reduced significantly in the
current era as illustrated by the results of Jahangiri and
colleagues.9 However, even taking into account the improved
postoperative survival data in the present era, there is no
suggestion that catheter intervention is a more risky
procedure than primary surgical outflow repair.
Despite evolution of management strategy, multiple inter-
ventions are still often required in the treatment algorithm
of PAIVS. The shift towards primary catheter intervention
for patients with PAIVS with a suitable anatomy has reduced
the occurrence of postprocedural low cardiac output syn-
drome. Although the optimal approach to relieve RV outflow
obstruction in PAIVS remains controversial, laser assisted
valvotomy with balloon valvoplasty proves to be an accep-
table alternative. Further studies to compare the cost
effectiveness and the severity of pulmonary regurgitation
and its impact on long term RV function between surgical
and catheter interventions may help to resolve the con-
troversy.
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Double mycotic aneurysm of the descending thoracic aorta
A
71 year old man was admitted with fever and chills. On
admission his temperature was 39 C˚; physical exam-
ination was normal except for a grade I/VI aortic
systolic murmur. Blood cultures and urine samples grew
Staphylococcus aureus. Transoesophageal echocardiography
(TOE) showed a mildly calcified aortic valve without
vegetations, and diffuse atheroma of the descending aorta.
Despite appropriate antibiotic treatment the patient remained
febrile, and developed clinical and radiological signs of
pulmonary oedema. A subsequent TOE revealed the presence
of two saccular aneurysms of the descending aorta, one just
beneath the isthmus (panel A: AO, aorta), and the second
one just above the diaphragm (panel B). These aneurysms
arose from two localised ruptures in the atheromatous intima
(arrows). The inferior one was responsible for a severe
compression of the left atrium and right pulmonary veins, as
shown by spectral and colour flow Doppler (panel C: LA, left
atrium; LV, left ventricle; MA, mycotic aneurysm). Magnetic
resonance imaging (spin echo T1 images) showed both
mycotic aneurysms with a severely inflammatory shell and
infiltration of the mediastinal fat, as well as the compressed
left atrium (panel D: AA, ascending aorta; Pl.E, pleural
effusion; RA, right atrium; RV, right ventricle; RPA, right
pulmonary artery). The patient was considered too ill for
surgery and died within a few days from multiorgan failure.
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